Skip to main content
SpringerLink
Log in

Finale Ergebnisse der PORTEC-3-Studie

RCT verbessert „failure-free survival“ beim Endometriumkarzinom im Stadium III

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Galaal K et al. Cochrane Database Syst Rev. 2014;(5):CD010681.

  2. Randall ME et al. J Clin Oncol. 2006;24 (1):36-44.

    Google Scholar 

  3. Hogberg T et al. Eur J Cancer. 2010;46(13):2422–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Matei D et al. J Clin Oncol. 2017;35(15_suppl):5505.

    Google Scholar 

  5. de Boer SM et al. Lancet Oncol. 2016;17(8):1114–26.

    Article  PubMed  Google Scholar 

  6. Cancer Genome Atlas Research Network et al. Nature. 2013;497(7447):67–73.

    Article  Google Scholar 

Originalie

  • De Boer SM et al. Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer. J Clin Oncol. 2017;35(15_suppl):5502.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Radioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland

    David Krug &  Nathalie Arians

Authors
  1. David Krug
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nathalie Arians
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Krug.

Additional information

Erstpubliziert in Strahlenther Onkol. 2017;193(12):1070-1.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krug, D., Arians, N. RCT verbessert „failure-free survival“ beim Endometriumkarzinom im Stadium III. Info Onkol. 21, 33–34 (2018). https://doi.org/10.1007/s15004-018-5957-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-5957-z

Schlüsselwörter

Search

Navigation